Filed under: pharmaceutical
Senate health debate hits snag over imported drugs
The idea of expanding access to lower-cost prescription medicines from overseas has broad support, but opposition from the U.S. drug industry could endanger the healthcare overhaul.
Read the Article>White House healthcare accord with drug industry may be going sour
Legislation passed by the House challenges the deal that pharmaceutical companies made with the Obama administration. They're prepared to make a stand in the Senate.
Read the Article>How Drug Companies Plan to Make a Killing Off of Health Care Reform
Congress Finally Stands Up to Big Pharma
A Rancid Deal with Big Pharma
So now we know why the president wants everyone to make nice in the healthcare debate. His White House has cut a deal with Big Pharma that smells like the same old rotten politics that candidate Obama regularly denounced and promised to end.
Read the Article>Democrats Say No to Cost Cap for Drug Makers
Squeezing more money out of the health care system, and from the drug industry, is still a goal for top Democrats.
Read the Article>